## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.3% in mid entry zone (3.0-6.0%), top 4% cross-sectional ranking. Short-term MRS_5 (2.8%) confirms momentum alignment. Momentum building (+0.8% 5-day). Outperforming sector by 3.4%. Caution: overbought RSI (78).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($47.69)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20251222T180840 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds investors of an upcoming January 12, 2026 deadline to file as lead plaintiff in a class action lawsuit against Freeport-McMoran Inc. (FCX). The lawsuit alleges the company made false or misleading statements and failed to disclose critical safety lapses at its Grasberg Block Cave mine, which led to a fatal incident and significant stock price drops. Investors who suffered losses between February 15, 2022, and September 24, 2025, are urged to contact the firm.

**2. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20251222T175553 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds investors of Freeport-McMoran Inc. (FCX) about a securities fraud lawsuit with a January 12, 2026 deadline to file as lead plaintiff. The lawsuit alleges that Freeport made misleading statements and failed to disclose critical safety issues at its Grasberg Block Cave mine in Indonesia, which led to multiple fatalities and significant stock price drops. Investors who suffered losses on their Freeport investments between February 15, 2022, and September 24, 2025, are urged to contact the firm.

**3. FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: GlobeNewswire | 20251222T160812 | Bearish | Relevance: 100%
- The Schall Law Firm is reminding investors of a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged securities fraud. The lawsuit claims that Freeport made false and misleading statements regarding safety practices at its Grasberg Block Cave mine in Indonesia, leading to investor losses. Investors who purchased securities between February 15, 2022, and September 24, 2025, are encouraged to contact the firm by January 12, 2026.

**4. Class Action Lawsuit Filed: Freeport-McMoRan Inc. (FCX) - Join by January 12, 2026 - Contact Levi & Korsinsky**
- Source: WIVB News 4 | 20251222T150815 | Bearish | Relevance: 100%
- A securities class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE:FCX) by Levi & Korsinsky, LLP on behalf of investors who sustained losses. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to heightened risks for workers and material misrepresentations about the company's prospects. Investors who purchased FCX securities between February 15, 2022, and September 24, 2025, are encouraged to inquire about their rights, with a deadline to join the case by January 12, 2026.

**5. FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: GlobeNewswire | 20251222T111000 | Bearish | Relevance: 100%
- The Schall Law Firm is reminding investors of a class action lawsuit against Freeport-McMoRan Inc. for alleged securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims Freeport made false and misleading statements by failing to ensure appropriate safety practices at its Grasberg Block Cave mine in Indonesia, leading to investor damages. Investors who suffered losses are encouraged to contact the firm before January 12, 2026.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.2x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.19 signals overvaluation risk, limited margin of safety. Forward P/E 22.4x attractive for 48% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (2 raises, avg +13%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.7B |
| Beta | 1.48 |
| 52W Range | $27.66 - $50.95 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.19 |
| Forward P/E | 22.4 |
| Current P/E | 33.1 |
| YoY Growth | 47.7% |
| EPS Direction | FALLING |

### Technicals

MRS_10 improving modestly (+0.8% over 5 days). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 95th percentile. MRS_5 at 2.8% confirms short-term momentum alignment. Outperforming sector by 3.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 78, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.33% (CS: 96) | Strong |
| RSI_14 | 78.5 | Overbought |
| MACD Histogram | 0.41 | Bullish |
| vs SMA20 | 1.114x | Above |
| vs SMA50 | 1.185x | Above |
| vs SMA200 | 1.232x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $50.65
- **Stop Loss:** $47.69 (5.8% risk)
- **Target:** $55.09 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 304
- **Position Value:** $15,397.60
- **Portfolio %:** 15.40%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*